BBGBloomberg·2hBusiness
score+0.50
Lilly to Buy Merida for $2.88B in Autoimmune Push
Original
Lilly to Buy Merida for $2.88B in Autoimmune Push
“Framed as strategic expansion and market diversification, using positive verbs like 'Push' and 'expand' to highlight growth.”